Darunavir population pharmacokinetics in pregnancy

HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds

I was like, oh my God, what happens if it doesn’t work’? Young people living with HIV, clinical trial participation and the truth economy

Raltegravir in HIV-1 Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

Ritonavir pharmacokinetics in pregnancy

Etravirine pharmacokinetics during pregnancy and postpartum

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women

I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV

Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?

“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV

Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV

Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?

‘I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV; accepted for presentation at AIDS Impact

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update Decemebr 2014

Pediatric drug safety surveillance in FDA-AERS: a description of adverse events from GRIP project.

Treating hepatitis C virus in children: time for a new paradigm